-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 K4am2qyAfIdIBr26hH3TRpGDzqUJlhqulNXYBF5L6qivg4v0og01AepK+BVQzVLI
 4cdAnkni2UZhG+3FM22ZpQ==

<SEC-DOCUMENT>0001336674-09-000003.txt : 20090707
<SEC-HEADER>0001336674-09-000003.hdr.sgml : 20090707
<ACCEPTANCE-DATETIME>20090707153047
ACCESSION NUMBER:		0001336674-09-000003
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20090707
DATE AS OF CHANGE:		20090707
EFFECTIVENESS DATE:		20090707

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viamet Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001336674
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-80342
		FILM NUMBER:		09933313

	BUSINESS ADDRESS:	
		STREET 1:		2250 PERIMETER PARK DRIVE
		STREET 2:		SUITE 320
		CITY:			MORRISVILLE
		STATE:			NC
		ZIP:			27560
		BUSINESS PHONE:		919-467-8539

	MAIL ADDRESS:	
		STREET 1:		2250 PERIMETER PARK DRIVE
		STREET 2:		SUITE 320
		CITY:			MORRISVILLE
		STATE:			NC
		ZIP:			27560
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0401</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001336674</cik>
        <entityName>Viamet Pharmaceuticals Inc</entityName>
        <issuerAddress>
            <street1>2250 PERIMETER PARK DRIVE</street1>
            <street2>SUITE 320</street2>
            <city>MORRISVILLE</city>
            <stateOrCountry>NC</stateOrCountry>
            <zipCode>27560</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>919-467-8539</issuerPhoneNumber>
        <issuerPreviousNameList>
            <previousName>Hephistics, Inc.</previousName>
        </issuerPreviousNameList>
        <jurisdictionOfInc>DELAWARE</jurisdictionOfInc>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <withinFiveYears>true</withinFiveYears>
            <value>2004</value>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Robert</firstName>
                <middleName></middleName>
                <lastName>Schotzinger</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>2250 Perimeter Park Drive</street1>
                <street2>Suite 320</street2>
                <city>Morrisville</city>
                <stateOrCountry>NC</stateOrCountry>
                <zipCode>27560</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Garheng</firstName>
                <middleName></middleName>
                <lastName>Kong</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Intersouth Partners VI, L.P.</street1>
                <street2>406 Blackwell Street, Suite 200</street2>
                <city>Durham</city>
                <stateOrCountry>NC</stateOrCountry>
                <zipCode>27701</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Douglas</firstName>
                <middleName></middleName>
                <lastName>Reed</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Hatteras Venture Partners III, LP</street1>
                <street2>280 S. Mangum Street, Suite 350</street2>
                <city>Durham</city>
                <stateOrCountry>NC</stateOrCountry>
                <zipCode>27701</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>William</firstName>
                <middleName>T.</middleName>
                <lastName>White, III</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Lurie Investment Fund, LLC</street1>
                <street2>440 W. Ontario Street</street2>
                <city>Chicago</city>
                <stateOrCountry>IL</stateOrCountry>
                <zipCode>60610</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Lauren</firstName>
                <middleName></middleName>
                <lastName>Silverman</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Novartis Option Fund</street1>
                <street2>Five Cambridge Center</street2>
                <city>Cambridge</city>
                <stateOrCountry>MA</stateOrCountry>
                <zipCode>02142</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>S. Edward</firstName>
                <middleName></middleName>
                <lastName>Torres</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Lilly Ventures Fund I, LLC</street1>
                <street2>115 West Washington Street, Suite 1680</street2>
                <city>Indianapolis</city>
                <stateOrCountry>IN</stateOrCountry>
                <zipCode>46204</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Neil</firstName>
                <middleName></middleName>
                <lastName>Moore</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>2250 Perimeter Park Drive</street1>
                <street2>Suite 320</street2>
                <city>Morrisville</city>
                <stateOrCountry>NC</stateOrCountry>
                <zipCode>27560</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Pharmaceuticals</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Decline to Disclose</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2009-06-23</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>17999996</totalOfferingAmount>
            <totalAmountSold>9999997</totalAmountSold>
            <totalRemaining>7999999</totalRemaining>
            <clarificationOfResponse></clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>7</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse>Other than the payment of salaries and other compensation and benefits no officer, director, or promoter will receive any payments from the proceeds of this offering.</clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>Viamet Pharmaceuticals Inc</issuerName>
                <signatureName>Robert Schotzinger</signatureName>
                <nameOfSigner>Robert Schotzinger</nameOfSigner>
                <signatureTitle>CEO</signatureTitle>
                <signatureDate>2009-07-07</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----